KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $8,243,000 | -21.6% | 826,000 | 0.0% | 1.10% | -32.6% |
| Q1 2015 | $10,515,000 | -25.7% | 826,000 | -17.4% | 1.62% | -25.5% |
| Q4 2014 | $14,150,000 | +2.9% | 1,000,000 | 0.0% | 2.18% | -22.8% |
| Q3 2014 | $13,750,000 | -37.5% | 1,000,000 | -41.2% | 2.83% | -55.7% |
| Q4 2013 | $22,015,000 | – | 1,700,000 | – | 6.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |